Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980 May;9(5):505–509.

The effect of metoclopramide and atropine on the absorption of orally administered mexiletine.

L M Wing, P J Meffin, J J Grygiel, K J Smith, D J Birkett
PMCID: PMC1429945  PMID: 6994791

Abstract

The effect of pretreatment with intravenous metoclopramide (10 mg) and atropine (0.6 mg), both separately and combined, on the absorption rate and relative oral bioavailability of the antiarrhythmic drug, mexiletinee (400 mg) was studied in eight fasting healthy males using a Latin Square design for order of pretreatment administration. The time (Tmax) of the maximum mexiletin plasma concentration (Cpmax) was reduced by metoclopramide (P < 0.001) and was increased by atropine (P < 0.01) compared with saline control. Tmax was not significantly altered by combined metoclopramide and atropine pretreatment. Atropine pretreatment was associated with a significant reduction of Cpmax (P < 0.05) and of elimination half-life (P < 0.05). The area under the mexiletine plasma concentration-time curve was not affected by any of the pretreatments. The results suggested that metoclopramide enhanced and atropine decreased the rate of mexiletine absorption without altering the relative oral bioavailability. When the pretreatments were administered in combination, metoclopramide reversed the delay in mexiletine absorption produced by atropine.

Full text

PDF
505

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adjepon-Yamoah K. K., Scott D. B., Prescott L. F. Impaired absorption and metabolism of oral lignocaine in patients undergoing laparoscopy. Br J Anaesth. 1973 Feb;45(2):143–147. doi: 10.1093/bja/45.2.143. [DOI] [PubMed] [Google Scholar]
  2. Campbell R. W., Julian D. G., Talbot R. G., Prescott L. F. Long term treatment of ventricular arrhythmias with oral mexiletine. Postgrad Med J. 1977;53 (Suppl 1):146–149. [PubMed] [Google Scholar]
  3. Danneberg P. B., Shelley J. H. The pharmacology of mexiletine. Postgrad Med J. 1977;53 (Suppl 1):25–29. [PubMed] [Google Scholar]
  4. Hagemeijer F. Absorption, half-life, and toxicity of oral aprindine in patients with acute myocardial infarction. Eur J Clin Pharmacol. 1975 Oct 10;9(1):21–25. doi: 10.1007/BF00613425. [DOI] [PubMed] [Google Scholar]
  5. Koch-Weser J., Klein S. W. Procainamide dosage schedules, plasma concentrations, and clinical effects. JAMA. 1971 Mar 1;215(9):1454–1460. [PubMed] [Google Scholar]
  6. Levy G., Gibaldi M., Procknal J. A. Effect of an anticholinergic agent on riboflavin absorption in man. J Pharm Sci. 1972 May;61(5):798–799. doi: 10.1002/jps.2600610529. [DOI] [PubMed] [Google Scholar]
  7. Mearrick P. T., Wade D. N., Birkett D. J., Morris J. Metoclopramide, gastric emptying and L-dopa absorption. Aust N Z J Med. 1974 Apr;4(2):144–148. doi: 10.1111/j.1445-5994.1974.tb03163.x. [DOI] [PubMed] [Google Scholar]
  8. Nimmo J., Heading R. C., Tothill P., Prescott L. F. Pharmacological modification of gastric emptying: effects of propantheline and metoclopromide on paracetamol absorption. Br Med J. 1973 Mar 10;1(5853):587–589. doi: 10.1136/bmj.1.5853.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nimmo W. S., Heading R. C., Wilson J., Tothill P., Prescott L. F. Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol. 1975 Dec;2(6):509–513. doi: 10.1111/j.1365-2125.1975.tb00568.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Nimmo W. S., Wilson J., Prescott L. F. Narcotic analgesics and delayed gastric emptying during labour. Lancet. 1975 Apr 19;1(7912):890–893. doi: 10.1016/s0140-6736(75)91687-6. [DOI] [PubMed] [Google Scholar]
  11. Prescott L. F., Pottage A., Clements J. A. Absorption, distribution and elimination of mexiletine. Postgrad Med J. 1977;53 (Suppl 1):50–55. [PubMed] [Google Scholar]
  12. Smith K. J., Meffin P. J. Mexiletine analysis in blood and plasma using gas chromatography and nitrogen-selective detection. J Chromatogr. 1980 Mar 14;181(3-4):469–472. doi: 10.1016/s0378-4347(00)81151-2. [DOI] [PubMed] [Google Scholar]
  13. Ward J. W., Kinghorn G. R. The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens. J Int Med Res. 1976;4(1 Suppl):49–53. [PubMed] [Google Scholar]
  14. Williams E. M. Mexiletine in isolated tissue models. Postgrad Med J. 1977;53 (Suppl 1):30–34. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES